FDA Looks To Standardize New Hepatic Warnings For Statins
FDA appears to be taking steps to standardize new safety labeling across the statin class of cholesterol-lowering drugs.
FDA appears to be taking steps to standardize new safety labeling across the statin class of cholesterol-lowering drugs.